Members |
acceptabilityId |
Azotobacter nigricans subspecies nigricans |
Preferred (foundation metadata concept) |
Azotobacter nigricans subspecies nigricans (organisme) |
Preferred (foundation metadata concept) |
Azotobacter salinestris |
Preferred (foundation metadata concept) |
Azotobacter salinestris (organisme) |
Preferred (foundation metadata concept) |
Azotobacter vinelandii |
Preferred (foundation metadata concept) |
Azotobacter vinelandii (organisme) |
Preferred (foundation metadata concept) |
Azovibrio restrictus |
Preferred (foundation metadata concept) |
Azovibrio restrictus (organisme) |
Preferred (foundation metadata concept) |
Aztèque |
Preferred (foundation metadata concept) |
Aztèque (groupe ethnique) |
Preferred (foundation metadata concept) |
Azymocandida curvata |
Acceptable (foundation metadata concept) |
Azymoprocandida humicola |
Acceptable (foundation metadata concept) |
Azymoprocandida japonica |
Acceptable (foundation metadata concept) |
Azymoprocandida japonica (organism) |
Preferred (foundation metadata concept) |
Açores |
Preferred (foundation metadata concept) |
Açores (lieu géographique) |
Preferred (foundation metadata concept) |
Aïnous |
Preferred (foundation metadata concept) |
Aïnous (groupe ethnique) |
Preferred (foundation metadata concept) |
BAAR - bacille acido-alcoolo-résistant |
Acceptable (foundation metadata concept) |
BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) |
Preferred (foundation metadata concept) |
BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Emergent BioSolutions Canada Inc. (real clinical drug) |
Preferred (foundation metadata concept) |
BAV - bloc auriculoventriculaire |
Acceptable (foundation metadata concept) |
BBD - bloc de branche droit |
Preferred (foundation metadata concept) |
BBG - bloc de branche gauche |
Preferred (foundation metadata concept) |
BBGD - biotin-thiamine-responsive basal ganglia disease |
Acceptable (foundation metadata concept) |
BBS - Bardet-Biedl syndrome |
Acceptable (foundation metadata concept) |
BBSOAS - Bosch-Boonstra-Schaaf optic atrophy syndrome |
Acceptable (foundation metadata concept) |
BCG Freeze-dried Glutamate BCG Vaccine (Japan) 0.5 microgram per milliliter powder and diluent for suspension for injection Japan BCG Laboratory (real clinical drug) |
Preferred (foundation metadata concept) |
BCG VACCINE 0.75 microgram per 1.0 milliliter liquid, powder for injection ID BIOMEDICAL COOPERATION OF QUEBEC (real clinical drug) |
Preferred (foundation metadata concept) |
BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Preferred (foundation metadata concept) |
BCG atténué |
Acceptable (foundation metadata concept) |
BCG bacille de Calmette-Guérin non spécifié |
Preferred (foundation metadata concept) |
BCG en instillation intravésicale |
Preferred (foundation metadata concept) |
BCG en instillation intravésicale (substance) |
Preferred (foundation metadata concept) |
BCG lyophilisé avec glutamate Japan JBCG |
Preferred (foundation metadata concept) |
BCG vaccin BCG SP |
Preferred (foundation metadata concept) |
BCG vaccin IDM |
Preferred (foundation metadata concept) |
BEXSERO suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Preferred (foundation metadata concept) |
BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) |
Preferred (foundation metadata concept) |
BFHD - Beukes familial hip dysplasia |
Acceptable (foundation metadata concept) |
BFLS - Borjeson-Forssman-Lehmann syndrome |
Acceptable (foundation metadata concept) |
BIG-IV BabyBIG CDPH |
Preferred (foundation metadata concept) |
BIG-IV immunoglobuline botulinique non spécifié |
Preferred (foundation metadata concept) |
BIMSE - benign infantile focal epilepsy with midline spikes and waves during sleep |
Acceptable (foundation metadata concept) |
BISECT - line bisection |
Preferred (foundation metadata concept) |
BISECT - line bisection (barème d'évaluation) |
Preferred (foundation metadata concept) |
BLC-PMG - bilateral band-like calcification with polymicrogyria |
Acceptable (foundation metadata concept) |
BMD - best vitelliform macular dystrophy |
Acceptable (foundation metadata concept) |
BMRS type V |
Acceptable (foundation metadata concept) |
BMS - burning mouth syndrome |
Acceptable (foundation metadata concept) |
BOFS - branchio-oculo-facial syndrome |
Acceptable (foundation metadata concept) |
BOOP - bronchiolite oblitérante avec organisation pneumonique |
Acceptable (foundation metadata concept) |
BOOSTRIX suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Preferred (foundation metadata concept) |
BOOSTRIX-POLIO suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Preferred (foundation metadata concept) |
BPAN - beta-propeller protein-associated neurodegeneration |
Acceptable (foundation metadata concept) |
BPCO |
Acceptable (foundation metadata concept) |
BSI - bathing suit ichthyosis |
Acceptable (foundation metadata concept) |
BSyn - Bloom syndrome |
Acceptable (foundation metadata concept) |
BVNP - bursite villonodulaire pigmentée |
Acceptable (foundation metadata concept) |
BWS - Beckwith-Wiedemann syndrome |
Acceptable (foundation metadata concept) |
Babesia |
Preferred (foundation metadata concept) |
Babesia (organisme) |
Preferred (foundation metadata concept) |
Babesia CA3 |
Preferred (foundation metadata concept) |
Babesia CA3 (organisme) |
Preferred (foundation metadata concept) |
Babesia EU1 |
Preferred (foundation metadata concept) |
Babesia EU1 (organisme) |
Preferred (foundation metadata concept) |
Babesia MO1 |
Preferred (foundation metadata concept) |
Babesia MO1 (organisme) |
Preferred (foundation metadata concept) |
Babesia argentina |
Preferred (foundation metadata concept) |
Babesia argentina (organisme) |
Preferred (foundation metadata concept) |
Babesia berbera |
Preferred (foundation metadata concept) |
Babesia berbera (organisme) |
Preferred (foundation metadata concept) |
Babesia bigemina |
Preferred (foundation metadata concept) |
Babesia bigemina (organisme) |
Preferred (foundation metadata concept) |
Babesia bovis |
Preferred (foundation metadata concept) |
Babesia bovis (organisme) |
Preferred (foundation metadata concept) |
Babesia caballi |
Preferred (foundation metadata concept) |
Babesia caballi (organisme) |
Preferred (foundation metadata concept) |
Babesia canis |
Preferred (foundation metadata concept) |
Babesia canis (organisme) |
Preferred (foundation metadata concept) |
Babesia capreoli |
Preferred (foundation metadata concept) |
Babesia capreoli (organisme) |
Preferred (foundation metadata concept) |
Babesia divergens |
Preferred (foundation metadata concept) |
Babesia divergens (organisme) |
Preferred (foundation metadata concept) |
Babesia duncani |
Preferred (foundation metadata concept) |
Babesia duncani (organisme) |
Preferred (foundation metadata concept) |
Babesia felis |
Preferred (foundation metadata concept) |
Babesia felis (organisme) |
Preferred (foundation metadata concept) |
Babesia foliata |
Preferred (foundation metadata concept) |
Babesia foliata (organisme) |
Preferred (foundation metadata concept) |
Babesia gibsoni |
Preferred (foundation metadata concept) |
Babesia gibsoni (organisme) |
Preferred (foundation metadata concept) |
Babesia jakimovi |
Preferred (foundation metadata concept) |
Babesia jakimovi (organisme) |
Preferred (foundation metadata concept) |
Babesia lotori |
Preferred (foundation metadata concept) |
Babesia lotori (organisme) |
Preferred (foundation metadata concept) |
Babesia major |
Preferred (foundation metadata concept) |
Babesia major (organisme) |
Preferred (foundation metadata concept) |
Babesia microti |
Preferred (foundation metadata concept) |
Babesia microti (organisme) |
Preferred (foundation metadata concept) |
Babesia motasi |
Preferred (foundation metadata concept) |